BALLIU, MANJOLA
 Distribuzione geografica
Continente #
EU - Europa 915
NA - Nord America 623
AS - Asia 97
Totale 1.635
Nazione #
PL - Polonia 684
US - Stati Uniti d'America 622
IE - Irlanda 59
IT - Italia 55
HK - Hong Kong 48
SE - Svezia 46
CN - Cina 18
CH - Svizzera 17
DE - Germania 15
VN - Vietnam 13
GB - Regno Unito 12
FI - Finlandia 10
BE - Belgio 8
JO - Giordania 7
KR - Corea 4
SG - Singapore 3
UA - Ucraina 3
ES - Italia 2
IN - India 2
NL - Olanda 2
RU - Federazione Russa 2
TR - Turchia 2
CA - Canada 1
Totale 1.635
Città #
Warsaw 684
Fairfield 92
Dublin 59
Ashburn 54
Chandler 54
Ann Arbor 53
Woodbridge 49
Cambridge 48
Houston 47
Seattle 44
Hong Kong 34
Wilmington 25
Lawrence 20
Altamura 19
Florence 18
Bern 17
New York 16
Princeton 15
Beijing 13
Dong Ket 13
Bremen 12
Brussels 8
Buffalo 8
Boston 7
Medford 7
San Diego 7
Boardman 6
Kent 5
Phoenix 5
Shanghai 5
Seoul 4
Jacksonville 3
Lappeenranta 3
Barcelona 2
Falls Church 2
Izmir 2
Maranello 2
Moscow 2
Norwalk 2
Pisa 2
Rimini 2
Rome 2
Andover 1
Fiesole 1
Fontebuona 1
Pune 1
Salerno 1
Schiavon 1
Singapore 1
Toronto 1
Wandsworth 1
Totale 1.481
Nome #
HDAC1 controls CIP2A transcription in human colorectal cancer cells 242
HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis. 223
Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells 218
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN 216
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis 149
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 141
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukemia cells 134
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 99
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring 91
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs 45
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2 42
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 23
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 17
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 16
Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1low model of myelofibrosis 11
CALR mutation burden in essential thrombocythemia and disease outcome 5
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells 2
Totale 1.674
Categoria #
all - tutte 4.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 0 39
2019/2020419 24 56 15 25 52 46 34 57 36 23 46 5
2020/2021286 19 40 1 45 21 35 18 22 24 34 8 19
2021/202296 3 6 12 2 3 4 2 13 6 7 15 23
2022/2023284 23 65 16 24 15 42 37 9 17 7 12 17
2023/2024150 2 10 17 4 14 31 1 44 1 8 11 7
Totale 1.674